Association of low and intermediate combined positive scores with outcomes of treatment with pembrolizumab in patients with recurrent and metastatic head and neck squamous cell carcinoma: Secondary analysis of keynote 048 Research Letter

   

Authors:	Yu, Y.; Zakeri, K.; Sherman, E. J.; Lee, N. Y.
Title:	Association of low and intermediate combined positive scores with outcomes of treatment with pembrolizumab in patients with recurrent and metastatic head and neck squamous cell carcinoma: Secondary analysis of keynote 048
Abstract:	This secondary analysis of the Keynote 048 trial examines treatment with pembrolizumab in patients with recurrent and metastatic head and neck squamous cell carcinoma.
Keywords:	confidence intervals; data analysis software; secondary analysis; descriptive statistics; treatment outcomes; neoplasm recurrence, local -- drug therapy; antibodies, monoclonal -- therapeutic use; cancer patients; neoplasm metastasis -- drug therapy; cox proportional hazards model; log-rank test; human; squamous cell carcinoma of head and neck -- drug therapy
Journal Title:	JAMA Oncology
Volume:	8
Issue:	8
ISSN:	2374-2437
Publisher:	American Medical Association
Date Published:	2022-08-01
Start Page:	1216
End Page:	1218
Language:	English
DOI:	10.1001/jamaoncol.2022.1846
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
PMCID:	PMC9185518
PUBMED:	35679031
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=158627761&site=ehost-live&scope=site&custid=s2915669
Notes:	Accession Number: 158627761 -- Entry Date: 20220830 -- Revision Date: 20220830 -- Publication Type: Article; letter; research; tables/charts -- Journal Subset: Peer Reviewed; USA. -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/197642